Adrenoleukodystrophy (ALD)
https://www.neurology.org/doi/10.1212/WN9.0000000000000096
Adrenoleukodystrophy (ALD) is a rare inherited condition that can damage the brain and nervous system. In some adults with ALD, inflammation in the brain can develop suddenly and progress quickly, leading to severe disability or loss of life if not identified early. Regular MRI brain scans are recommended as they can detect these changes before major symptoms appear. Early diagnosis is crucial in patients that will benefit from stem cell transplantation, which can slow or stop disease progression when performed at the right stage. This study examined national trends in the United States to understand how often adult men with ALD receive recommended MRI screening and how frequently they undergo transplantation treatment. The researchers reviewed healthcare data to assess whether screening and treatment practices have changed over time. Men with ALD ages 18 years and older were included between years 2008 and 2024. The study found that MRI screening has increased in recent years, suggesting that awareness of adult ALD monitoring is improving. However, many patients still do not receive scans as often as recommended by clinical guidelines. The findings also showed that relatively few patients undergo transplantation, despite the potential benefits of early intervention for selected individuals. These results highlight important gaps in care for adults living with ALD. The researchers suggest that improving access to regular MRI monitoring, increasing awareness among healthcare professionals, and identifying patients earlier could help ensure that more people receive timely treatment and better long-term outcomes.